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ABSTRACT
The overall goal of this Doctor of Nursing Practice (DNP) scholarly project is to
complete a program evaluation using the Centers of Disease Control (CDC) Framework
for Program Evaluation to measure the effectiveness of a stroke protocol in a rural
Nevada hospital. This (DNP) scholarly project evaluates program strategies over third
and fourth quarters of 2010 as well as the first, second, and third quarters of 2011, that
have been initiated to reduce the burden of neurological disease with the application of a
stroke protocol that complies with defined evidence-based strategies for assessment and
management of stroke victims. As part of a continuous quality-improvement effort, the
implementation of eight quality-of-care stroke measures have been monitored on a
quarterly basis both pre and post initiation of the stroke protocol.
The program evaluation of stroke protocol in a rural Nevada hospital evaluates
systematic ways to improve procedures that are useful, feasible, ethical, and accurate.
Application of the Centers of Disease Control (CDC) Framework for Program Evaluation
answers questions by selecting specific evaluation standards. The logic, reasoning, and
values of evaluation that are reflected in this framework can lead to lasting impacts, such
as basing decisions on experimentation instead of unfounded assumptions. The specific
aim of this program evaluation was to analyze the start of a new program within a rural
Nevada hospital, to produce information for evaluating the stroke program’s
effectiveness, and to use this information to make decisions about program refinement,
revision, and /or continuation. The key to stroke recovery is through early intervention
and treatment.
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CHAPTER I
Introduction
The Nevada State Health Division (NSHD) (2011) reports stroke as the third most
common cause of death in the United States, preceded only by heart disease and cancer.
There are five leading causes of death in Nevada (NSHD, 2011). These include heart
disease, cancer, chronic lower respiratory disease, unintentional injuries, and stroke. The
2008 mortality rate due to stroke in Nevada is reported to be 40.2/100,000 U.S.
Population (NSHD, 2011). According to the National Vital Statistics Report, 847
Nevadans died from stroke in 2006, constituting 4.5% of total deaths in Nevada
(Kochanek, Jiaquan, Murphy, Minino, & Kung, 2011). In Nevada, approximately 10,000
people suffer strokes each year that cause significant morbidity and disability (NSHD,
2011).
Cardiovascular disorders, primarily strokes, are a major cause of disability and
contribute to increases in health care costs due to the serious nature of neurological
emergencies and the often necessary subsequent hospitalization (NSHD, 2011). Twentynine percent of all strokes are recurrent, and disability commonly manifests as a result.
Twenty-nine percent of all strokes are recurrent, and disability commonly manifests as a
result (Urden, Stacy, & Lough, 2009). When cerebral blood vessels become occluded by
thrombus or embolus, or when intracranial hemorrhage occurs, the brain tissue becomes
ischemic, resulting in a stroke (Wilson & Giddens, 2008). The key to stroke recovery and
reducing stroke morbidity, mortality, and disability is through early preventive screening,
early invention, and treatment (NSHD, 2011).
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The estimated economic burden of stroke care is greater than $40 billion per year the
U.S. (McCance & Huether, 2009). The Milken Institute (2007) released a recent study
titled, An Unhealthy America: The Economic Impact of Chronic Disease. This study
provided a report of Nevada’s estimated medical costs for the treatment of stroke. The
Milken Institute used statistics based on the 2003 Medical Expenditure Panel Survey data
(NSHD, 2011). As of 2003, Nevada’s annual cost burden from stroke totaled $700
million (Milken Institute, 2007). According to the Medical Expenditure Panel Survey
data for Nevada Medicaid recipients (Milken, 2007, the cost of stroke treatment was
estimated to be $31.7 million (Nevada Council State Legislatures, 2011).
There is a pressing need for research specific to Nevada regarding stroke to reduce
this health disparity in incidence rates and case-mortality rates. The Nevada Integrated
System of Stroke Prevention identifies three main goals for the prevention, treatment, and
effective case management of stroke in Nevada. The Nevada Multidisciplinary Team
(NSHD, 2011) identifies gaps in service by reviewing and evaluating current practices
and policies. These goals are defined as follows:
1. Identification of all patients who receive treatment from Nevada emergency
departments for possible acute stroke;
2. Promotion and support of quality improvement efforts, interventions, and system
alterations, and
3. Systematic collection and analysis of data for the assessment of outcomes
influenced by intervention (Assam, 2011).
In this program evaluation, an ischemic stroke protocol in a rural Nevada hospital has
been evaluated. Ischemic stroke results from low cerebral blood flow (CBF), usually
2

caused by an occlusion of the blood vessel (Urden, Stacy, & Lough, 2009). The occlusion
can be thrombotic or ischemic. Eighty percent of all strokes are ischemic (McCance &
Huether, 2009).
Ischemic strokes are preventable, whereas most thrombotic strokes result from the
accumulation of atherosclerotic plaque (Urden, Stacy, & Lough, 2009). “Improving the
quality of stroke care is a global priority, despite the diverse healthcare economies across
nations” (Joint Commission International, 2010, p. 2). The potential of information
technology for quality improvement by developing new systems of data collection
provide additional opportunities to track, trend, and compare stroke performance
measures (American Heart Association, 2001). The importance of identifying stroke
information strongly affects the course of events that establish quality of care. Progress
toward the goal of a structured approach to performance improvement maximizes
learning of overall practice performance and capabilities while reducing the number and
severity of stroke symptoms (American Heart Association, 2001).
The stroke (STK) core measures were developed in collaboration with the American
Heart Association (AHA)/American Stroke Association (ASA)/Brain Attack Coalition
(BAC) for use by Disease-Specific Care (DSC)-certified primary stroke centers (The
Joint Commission, 2011). The collaborative development process was facilitated by the
expertise and advice of the Disease-Specific Care Stroke Advisory Panel guided by
direction of the measure specifications with data elements contained in the AHA Get
With The Guidelines (GWTG)-Stroke patient management tool and the Centers for
Disease Control and Prevention (CDC) (The Joint Commission, 2011).
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In health care performance, excellence requires that results are measured, trended,
and compared with prior performance or best in the industry performance, and that best
practices are deployed and aligned in a practice or on an organization-wide basis
(American Heart Association, 2001). A standard set of core performance stroke measures
can facilitate a common language that promotes benchmarking and sharing of best
practices (American Heart Association, 2001). The Joint Commission (TJC) (2011)
adopted and required reporting on the eight stroke (STK) core performance measure set,
which are often referred to as core measures. Core performance measures are a common
set of measurement specifications (See Appendix B). Prompted by the requirement that
stroke core performance measures are reported, this rural Nevada hospital’s stroke
protocol has been adjusted for compliance with Joint Commission on Accreditation of
Healthcare Organizations (JACHO). The JACHO is an independent organization that
accredits and certifies health-care organizations, and makes program recommendations
that meet the Centers for Medicare and Medicaid Service (CMS) regulations for
reimbursement. The measure set is applicable to patients with the international
classification diagnoses of ischemic stroke (See Appendix C) designed to promote
international comparability in the collection, processing, classification, and presentation
of mortality statistics (CDC, 2011b).
Problem Statement
Initial STK core performance measure data in the third quarter of 2010 reported that
one out of four stroke patients received venous thromboembolism prophylaxis (VTE), in
a manner compliant with treatment recommended by JACHO and CMS. The National
Quality Forum (NQF) a nonprofit organization that operates to improve the quality of
4

healthcare and TJC consider VTE to be the most common preventable cause of hospitalrelated death, with an estimated 300,000 VTE-related deaths annually (Michota, 2007).
This data prompted a need for immediate action including policy adaption and use of
telemedicine.
The stroke protocol (See Appendix D) for patients in this rural Nevada hospital was
initiated for patients reporting to the emergency department with any or all of the
following eight stroke symptoms: (a) altered state of consciousness; (b) aphasia, or other
higher cognitive disturbance; (c) dysarthia; (d) facial weakness or asymmetry; (e) lack of
coordination, weakness, paralysis, or sensory loss of one or more limbs; (f) ataxia, poor
balance, clumsiness, or difficulty walking; (g) visual loss; and (h) vertigo, double vision,
unilateral hearing loss, nausea, vomiting, headache, photophobia, or phonophobia.
The stroke protocol was adapted to serve a rural population without the benefit of
specialized service providers. The northeastern region of Nevada is without a neurologist.
Plans for the implementation of the adapted stroke protocol, including the use of
telemedicine for consultation and examination, were planned for implementation in April,
2011 as a means of providing medical care. Electronic communication requires the
acquisition and use of advanced and interactive telecommunication equipment that
permits direct communication between the patient and the physician at the remote site
(Centers for Medicare & Medicaid Services, 2010).
Initial plans for partnership with a Nevada certified stroke center were met with
difficulty and ultimately failed in an attempt to contract services with a neurologist,
neurology group, and health care organization. Plans have continued to promote
partnerships at the local and state level in order to provide quality stroke care to the rural
5

population of northeastern Nevada. There are nine primary stroke centers in Nevada,
eight in Clark County, and one in Washoe County (NSHD, 2011). The particular rural
Nevada hospital involved in the study is more than 300 miles from the nearest Nevada
stroke center (U.S. Census Bureau, 2011a).
This program evaluation, based on the CDC Framework for Program Evaluation,
analyzed the start of a new program within a rural Nevada hospital that provided
information for evaluating the stroke program’s effectiveness, and used information to
make decisions about program refinement, revisions, and /or continuation (See Appendix
E).
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CHAPTER II
Review of the Literature
Researchers make the point of explaining the significance of supporting early stoke
intervention and treatment. The incidence of stroke affects 5,000 people each year, and 514% of the survivors will experience a second stroke within one year of the first stroke
(McCance & Huether, 2009). Rural populations have been identified as being particularly
vulnerable to stroke (U.S. Census Bureau, 2011b). The CDC (1999) estimates from the
National Health Survey that stroke in the United States is 1.45 times more prevalent in
rural than urban areas. Strong, Mathers, and Bonita (2007) indicate that adherence to
best-practice stroke care guidelines would reduce the incidence of stroke by 80%.
However, despite the availability of the National Stroke Guidelines, only 50% of rural
hospitals are reported to use them (Joubert, et al., 2008).
Eighty percent of strokes are ischemic, with the three main causes including
atherosclerotic disease of large extracranial, intracranial vessels, occlusion of intracranial
vessels by emboli from a cardiac source, and small vessel intracranial occlusive disease
from hypertension and diabetes (Burke & Laramie, 2004). Ischemic stroke patients
treated with thrombolytic therapy such as t-PA within three hours of onset experience
significantly improved outcomes and irreversible neuronal damage (Burke & Laramie,
2004). Considering that time is of great importance in terms of the reversibility of brain
ischemia, treatment needs to be initiated promptly (McCance & Huether, 2009).
Implementation of best-practice recommendations for stroke management in rural
areas is often suboptimal (American Heart Association, 2008). The quality of stroke
services for rural patients is variable with contributing factors that can include difficult
7

terrain, long distances to hospitals, poor transportation and communications, traditional
practices, lack of medical services and personnel, and lack of equipment, lack of
hospitalization, and financial support (American Heart Association, 2008).
Organizations such as the American Evaluation Association (AEA) are devoted to the
application and exploration of program evaluation, personnel evaluation, technology, and
many other forms of evaluation. The AEA (2008) believes that “evaluation involves
assessing the strengths and weaknesses of programs, policies, personnel, products, and
organizations to improve their effectiveness” (p. 7). Additionally, the AEA (2008)
advises that program evaluation increases and promotes use of evaluation data, while
contributing to theory and knowledge development of effective human action. Program
evaluation is an essential organizational practice in public health, however, it is not
practiced consistently across program areas, nor is it well-integrated into the day-to-day
management of most programs (CDC Evaluation Working Group, 2008). Program
evaluation is also necessary to fulfill CDC's operating principles for public health, which
include using science as a basis for decision-making and action, expanding the quest for
social equity, performing effectively as a service agency, making efforts outcomeoriented, and being accountable (CDC Evaluation Working Group, 2008). This analysis
establishes and creates research credibility for program evaluations.
The CDC Evaluation Working Group suggests that evidenced based research,
particularly in program evaluation, is important for its management and improvement.
Additionally, this working group identified the need for the development of plans,
partnerships, and feedback systems that provide a path for learning and ongoing
improvement (CDC Evaluation Working Group, 2008).
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The CDC Framework for Program Evaluation is described as a “driving force for
planning effective strategies, improving existing programs, and demonstrating the results
of resource investments” (U.S. Department of Health and Human Services, 1999, p. 1).
The recommended framework facilitates an integration of program evaluation that can be
used to promote health and prevent disease and injury. The U.S. Department of Health
and Human Services (1999) describe the CDC Framework for Program Evaluation as
applicable to almost any organized public health activity including systems, policy
development activities, outbreak investigations, laboratory diagnostics, communication
campaigns, infrastructure building projects, training and educational services, and
administrative systems.
In 2003, the CDC Framework for Program Evaluation was used to assess tuberculosis
contact investigation programs in Massachusetts. In this program evaluation three of the
six steps of the CDC’s framework were utilized to engage and identify stakeholders,
create a logic model describing the tuberculosis program components, and develop selfevaluation tools. Conclusion findings credit the CDC framework with providing a useful
methodology for beginning the assessment of tuberculosis contact investigation programs
with findings used to target areas in need of improvement (Boutotte, Wilce, & Etkind,
2003).
In 2005, the Diabetes Primary Prevention Initiative Interventions Focus Area
implemented the CDC Framework for Program Evaluation in five state-level diabetes
prevention and control programs to translate diabetes primary prevention trails
(Porterfield, Hinnant, Stevens, & Moy, 2005). Evaluation findings summarized
recommendations for future community-based diabetes prevention initiatives, and
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identified the need to strengthen clinical-community partnerships for the referral of
people to evidence-based lifestyle programs (Porterfield, Hinnant, Stevens, & Moy,
2010).
In 2010, New York State Department of Health announced plans to eliminate
childhood lead poisoning by developing and implementing an evaluation of the lead
elimination plan. The CDC Framework for Program Evaluation was chosen as the design
for the evaluation, and will be utilized to measure progress, accomplishment of specific
plan components, overall coordination of plan efforts, and statewide outcomes (New
York State Department of Health, 2010). Evaluation findings will be used to refine and
improve the elimination plan.
As can be seen the CDC framework contributes to the achievement of research that is
useful in program evaluation processes. Program evaluation can emerge from a variety of
sources and settings all of which have an emphasis on the significant usefulness and
importance of evidenced based practice to generate positive outcomes.
Needs Assessment
The Department of Health and Human Services Centers (DHHS) for the CDC Heart
Disease and Stroke maps the applications of data for heart disease and stroke mortality
and hospitalization rates. This application allows for the visualization of national, state,
and county rates for stroke mortality and resulting hospitalizations (See Appendix E &
F). Nevada state statistics report stroke death rates from 2000-2006 as 94% of the total
population of 35 year olds and older (totaling1,269,670), compared to the national stroke
death rate of 98%. Elko County Nevada is reported as having one of the lowest stroke
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hospitalization rates in the state, although has the second highest stroke mortality rate in
the state (CDC, 2011a).
Casper, Wing, Anda, Knowles, and Polland (2011) list the disease determinants for
stroke as:
1. Medical diagnosis
•

Hypertension

•

Hyperlipidemia

•

Cardiovascular disease

•

Diabetes mellitus

•

History of stroke or transient ischemic attack

•

Hematological disorder

2. Individual lifestyle and behaviors

3.

•

Smoking

•

Alcohol consumption

•

Sedentary lifestyle

•

Inadequate nutrition

Genetic predisposition includes
•

Family history of heart disease, high blood pressure, and stroke

•

Gender: At a younger age men are at a higher risk of stroke than women. At
an older age female are more likely to have a stroke than men.

•

Race/ethnicity: At a younger age African Americans, Hispanics, and
American Indian/Alaska Natives are more likely to a have a stroke than nonHispanics, Asians or Caucasians (Casper, et al., 2011).
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The NSHD (2011) report gives a descriptive analysis of the epidemiology of stroke in
Nevada. Other sources of analysis include Nevada Behavioral Risk Factors Surveillance
Survey (BRFSS), and Centers of Disease Control and Prevention (CDC). The stroke
prevalence and frequency rates were analyzed in accordance with age groups, gender,
race/ethnicity, and educational level by BRFSS. Members of the population aged 18
years and older were selected for the analysis. According to the data, the stroke
prevalence differed in relation to racial/ethnic groups, education level, and income level.
The incidence of stroke is higher in the aged population. The 65 and older age group
demonstrated a higher prevalence of stroke than the group of persons aged 18-44 years.
The number of women having had a stroke have a longer life expectancy than that of men
(Assam, 2011).
A lower stroke prevalence rate was seen in the more highly educated portion of the
population, as compared to the portion of the population with less than a high school
education. Stroke was also observed to occur more frequently among African Americans
(4.7%) than Hispanics (0.77%) and Caucasians (2.63%). There was a significant
difference in stroke prevalence observed in different areas of Nevada (NSHD, 2011).
Research provides important contributory data to further understand and clarify this
health disparity in relation to demographics of the defined population.
Population identification. As of the 2009 census, the population of Elko County,
Nevada was 47,896 with 15,638 households, and 11,493 families residing in the county
(U.S. Census Bureau, 2011a). The U.S. Census Bureau defines rural as a term of
exclusion (American Heart Association, 2008). Elko, County, Nevada has a land area of
17,179.03 square miles with 2.6 persons per square mile (U.S. Census Bureau, 2011a).
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This rural Nevada hospital is located in Elko, Nevada, which is 300 miles east of Reno,
Nevada, 240 miles west of Salt Lake City, Utah, and 250 miles south of Boise, Idaho. It
is important to understand that areas in rural Nevada surrounding Elko lack accessible
healthcare services and specialty care is very limited. Maintaining an optimal level of
care is crucial because stroke patients in the rural Nevada area access services through
this hospital’s emergency room.
Prior to the start of the third quarter of 2010, stroke evaluation and treatment was left
to the discretion of the emergency room physician, and included air transport time of a
minimum of one hour to the nearest facility providing neurological care. In the past
methods used to provide stroke care services, lacked a standard set of clinical measures
for providers, health systems, and payers used to monitor the quality of care (American
Heart Association, 2001). As the health care system has changed with the demand of high
quality standards, so has this rural Nevada hospital’s search for ways to deliver care and
simultaneously gain efficiency.
Identification of project sponsor and key stakeholders. The stroke protocol is
funded by the rural Nevada hospital and directs the evaluation of stroke patients in hopes
of the institution of rapid, informed guideline protocols. Additional stakeholders include
clinical professionals and health care consumers. This organizational chart is available in
Appendix H.
Organizational assessment. The roles of organizations endeavoring to create a
culture of quality and continuous improvement cannot be underestimated (Baker, 2009).
At the prompting of mandatory reporting of stroke core performance measures this rural
Nevada hospital’s stroke protocol has been adjusted to accommodate Joint Commission
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on Accreditation of Healthcare Organizations (JACHO) recommendations, and to meet
Centers for Medicare and Medicaid Service (CMS) regulations for reimbursement.
Mandatory reporting and potential loss of reimbursement for care if noncompliant with
evidence based practice STK measures prompted a need for immediate action including
policy adaption.
Assessment of available resources. Hospital privilege has been granted to
participate in the review and gathering of Stroke Core Performance Measures which
consists of CMS reportable data as part of continuous quality improvement.
Team selection and formation. Consideration was given regarding organizational
team activities designed to generated the best outcomes, acknowledging the six basic
roles in a quality improvement team: team leader, team member, recorder, timekeeper,
quality advisor, and executive champion. The nursing quality director was charged with
the task of developing a process to adapt a stroke protocol that would meet mandatory
compliance recommendations for reimbursement. The team members included managing
information technology, nursing supervisors and nursing directors from the emergency
room, medical, surgical, pediatric, obstetrics, and intensive care unit. The Chief Nursing
Officer and Quality Director served as the executive champions.
Cost benefit analysis. Economics of health care delivery are the lifeline for health
care organizations and providers. The estimated economic cost of stroke care is greater
than $40 billion per year (McCance & Huether, 2009). According to Medical Expenditure
Panel Survey data for Nevada Medicaid recipients the price of stroke was estimated to be
$31.7 million (NSHD, 2011). Knowledge of the current and expected quality measures
for compliance with Continuous Quality Improvement (CQI) positively improves care
14

and controls cost (McLaughlin & Kaluzny, 2006). Pressure to increase quality and lower
costs is coming from accreditation agencies, the public, the media, insurers, and
governmental agencies (McLaughlin & Kaluzny, 2006.) The Patient Protection and
Affordable Care Act (PPACA) of 2010, better known as healthcare reform, was designed
to change our health delivery system. A major challenge affecting healthcare
organizations and providers is the implementation of new payment models. Health reform
moves healthcare organizations and providers from the traditional fee-for-service
environment to an accountable care environment that ties reimbursement to quality. This
does several things; it increases quality, decreases costs, and pays for performance
(Christensen, Grossman, & Hwang, 2009). The accountable care model/delivery payment
system requires healthcare organizations to be responsible for coordinating care to
improve patient outcomes. Healthcare organizations are held accountable for the care
they give and reimbursement is impacted by the quality of care delivered.
Accountable Care Organizations (2009) describe a growing consensus of efforts to
improve care and foster greater accountability for both quality and cost and include
several guiding principles for reform, such as require local accountability, allow for
variation in strategies that local health care systems use to improve care, and promote
improved care at a lower cost.
Stroke core measures provide evidence based patient care that is shown to produce
the best outcomes. Organizational fiscal needs are based on service growth and intensity.
Compliance data is publicly reported. Quality has become an important component in the
evaluation of healthcare organizations and is necessary to reduce avoidable complications
and unnecessary costs. Sustainable growth is achieved through quality care. Voluntary
15

reporting of data allows for maximum reimbursement. Efforts to measure and improve
quality are what make CQI successful.
Defining the scope of the project. This program evaluation based on the CDC
Framework for Program Evaluation is used to analyze the start of a new program within a
rural Nevada hospital to produce information for evaluating the stroke program’s
effectiveness and to use this information to make decisions about program refinement,
revisions, and /or continuation.
Project evaluation questions. A set of 10 Stroke (STK) performance measures
derived from published care guidelines and clinical trials. Eight of the 10 measures
received endorsement and inclusion by the National Quality Forum (NQF) and CMS as
evidenced-based measures of care. All measures were adopted except STK-7 dysphagia
screening and STK-9 smoking cessation. Although swallowing assessment is important
for many patients for the prevention of aspiration pneumonia, dysphagia screening was
not endorsed by the NFQ because the screenings are currently not well defined and use
varying techniques, lack of a valid, reliable, standardized screening tool or process that is
supported by research, and the reviewed literature showed that 50% of African
Americans were under represented (LaBresh, 2008). Smoking cessation is a core
performance outcome measure for hospitals that mandates the documentation of the
tobacco-use status of all admitted patients (The Joint Commission, 2011). Hospital are
required to provide both cessation counseling and medication during hospitalization for
all identified tobacco users.
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Evaluation questions include the Stroke (STK) Core Performance Measure Set:
•

STK-1 Venous Thromboembolism (VTE) prophylaxis

•

STK-2 Discharged on antithrombotic therapy

•

STK-3 Anticoagulation therapy for atrial fibrillation/flutter

•

STK-4 Thrombolytic therapy

•

STK-5 Antithrombotic therapy by end of hospital day 2

•

STK-6 Discharged on statin medication

•

STK-8 Stroke education

•

STK-10 Assessed for rehabilitation

Policy implications. Hospitals that participate with Medicare and Medicaid services
are required to successfully undergo Joint Commission accreditation. Healthcare payors
expect hospitals providing services to not only comply with controls and standards but to
also furnish measurable assurance (Joint Commission International, 2010).
If the patient onset is within two hours of arrival, the patient must have thrombolytic
treatment within one hundred eighty minutes of onset or the healthcare facility must
provide a documented contraindication. Thrombolytic therapy is the use of drugs to break
up or dissolve blood clots, which are the main cause of stroke (National Institutes of
Health, 2011). Venous Thromboembolism Prophylaxis (VTE) must be administered the
day of admission or the day after for non-ambulatory patients or a documented
contraindication. Ischemic stroke patients must have antithrombotic therapy administered
by end of day two or a documented contraindication. Patients must be assessed for
rehabilitation services or a documented contraindication. Stroke/Transient Ischemic
Attack (TIA) patients are required to have neurological checks every two hours for
17

assessment of neurological deficits. Low-density lipoprotein (LDL) must be measured in
the first 48 hours of arrival. Antithrombotic therapy must be prescribed at discharge or a
documented contraindication. Patients with atrial fibrillation/flutter a cardiac irregularity
must have anticoagulation therapy to decrease the risk of developing a blood clot at
discharge or a documented contraindication. Ischemic stroke patients with an LDL
greater than or equal to 100mg/dl, or LDL not measured or patients who were on lipid
lowering medication prior to hospital arrival need to be discharged on a HMG-CoA
Reductase Inhibitor (Statins) medication or a documented contraindication. Statins
decrease blood clot formation. There are several instances when statins are
contraindicated such as with active liver disease and during pregnancy (Arcangelo &
Peterson, 2006).
Procedure.
•

Step one: Engage key stakeholders such as those involved in program operations,

those served or affected by the program, and those who are intended users of evaluation
findings (U.S. Department of Health and Human Services, 2005). Obtain a formal letter
of hospital approval for evaluation of stroke program (See Appendix G). The program
stakeholders include the hospital, clinical professionals, and health care consumers.
Create an established organizational chart (See Appendix H).
•

Step two: Describe the program with a comprehensive description clarifying need,

targets, outcomes, activities, and resources. (U.S. Department of Health and Human
Services, 2005). Standards of accuracy and propriety apply most directly to describing
the program (U.S. Department of Health and Human Services, 2005). This program
evaluation describes program strategies over the third and fourth quarters of 2010 as well
18

as the first, second, and third quarters of 2011, that have been and will be initiated to
reduce the burden of neurological disease with the application of a stroke protocol that
complies with defined goals for the assessment and management of stroke victims.
•

Step three: Focus the evaluation design with stakeholders to define purpose and

uses of evaluation (U.S. Department of Health and Human Services, 2005). Application
of the Centers of Disease Control (CDC) Framework for Program Evaluation will answer
questions by selecting evaluation strategies that are useful, feasible, ethical, and accurate.
•

Step four: Gather credible evidence including consideration of indicators, sources

of evidence/ methods of data collection, quality, quantity, and logistics (U.S. Department
of Health and Human Services, 2005). The program evaluator, with the assistance of the
hospital’s utilization review board, will select patient charts at the end of each quarter
based on the ICD code table for stroke diagnoses. For the purpose of this program
evaluation, Starla Ricks MSN, FNP-BC will function as the program evaluator. The
Stroke Core Performance Measures which consists of Joint Commission & CMS
reportable data, which will be abstracted to determine whether measures have or have not
been met. Data abstraction will take place following the last day of the previous quarter.
Compilation of data and interpretation of data based on stroke performance measures.
•

Step 5: Justify conclusions by “analyzing the evidence, making claims about the

program based on the analysis, and justifying the claims by comparing the evidence
against stakeholder values” (U.S. Department of Health and Human Services, 2005).
Compare quarterly core performance measures.
•

Step 6: Ensure use of evaluation findings and shared lessons learned to improve

program. Five elements important to usefulness include providing recommendations,
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preparation, feedback, follow up, and dissemination (U.S. Department of Health and
Human Services, 2005). Final evaluation of program based on data findings. Standards of
utility, propriety, and accuracy most directly relate to ensuring use and sharing lessons
learned (U.S. Department of Health and Human Services, 2005).
Mission, Goals, and Objectives Statements
This program evaluation of stroke protocol in a rural Nevada hospital evaluates a
systematic way to improve and account for actions that involve procedures that are
useful, feasible, ethical, and accurate. Compliance with defined goals for assessment and
management are essential in the determination of financial reimbursement for care within
this practice setting. Application of the Centers of Disease Control (CDC) Framework for
Program Evaluation answers questions by selecting evaluation standards that are useful,
feasible, ethical, and accurate. The logic, reasoning, and values of evaluation that are
reflected in this framework can lead to lasting impacts, such as basing decisions on
systematic judgments instead of unfounded assumptions. The specific aim of this project
is to analyze the start of a new program within a rural Nevada hospital to produce
information for evaluating the stroke program’s effectiveness and to use this information
to make decisions about program refinement, revisions, and /or continuation. The key to
stroke recovery is through early intervention and treatment.
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CHAPTER III
Theoretical Underpinnings of the Project
The recommended Framework for Program Evaluation is the Centers of Disease
Control (CDC) model of program evaluation [see Appendix E] (Mateo & Kirchhoff,
2009). The CDC model was constructed to ensure that amid the complex transitions in
health care, program directors, sponsors, and leaders remain accountable and committed
to achieving measurable health outcomes (Billings, 2000; CDC Evaluation Working
Group, 2008; Boutotte, Wilce, & Etkind, 2003).
Mateo and Kirchhoff’s (2009) describe the Framework for Program Evaluation as a
practical, non-prescriptive tool, designed to summarize and organize the essential
elements of program evaluation. The Framework for Program Evaluation is useful when
performing program evaluations. After data are collected, findings will be reviewed, and
the degree to which criteria was met will be evaluated. Expected standards of program
evaluation hinge upon four core concepts, which are central to the framework: utility,
feasibility, propriety, and accuracy (Mateo & Kirchhoff, 2009).
Underlying the CDC Framework for Program Evaluation are the five guiding
principles of systematic inquiry, competence, integrity and honesty, respect for people,
and commitment to public welfare, and are adapted from the CDC 1999. The American
Evaluation Association (2008) proposes that such principles guide professional
evaluation and are clearly defined to the public.
Major concepts described in the CDC Framework for Program Evaluation are used to
describe the program evaluation steps (CDC Evaluation Working Group, 2008). Steps for
formative and summative evaluation include engaging stakeholders, describing the
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program, focusing the evaluation plan, gathering credible evidence, and justifying
conclusions.
Theory to Support Change
In healthcare, the real goal is to always provide better patient care. Change potentiates
the possibility of accomplishing this goal. Decisions about the quality of clinical
outcomes take into account quality concern, improvement opportunities, and whether
there is evidence to support considering a change. Hinshaw and Grady (2011) reminds us
that despite the knowledge that evidence-based practice (EBP) improves healthcare
quality and reduces morbidities, mortality, costs, and geographic variation of healthcare
services, it is not standard practice in numerous health systems across the United States.
Hinshaw and Grady (2011) further elaborate on the viewpoint that “many clinicians
in a multitude of settings across the care continuum continue to deliver care to their
patients based upon tradition, information that was learned years before in their
educational programs, and outdated policies and procedures that exist in institutions” (p.
87). Change is required when implementing a continuous quality improvement initiative
(Zaccagnini & White, 2011).
One of the earliest and perhaps the most useful change method theories is Lewin’s
(1951) force-field model that identified three phases of change: first, unfreezing, in which
people are preparing for change; second, moving, in which people have accepted the need
for a change and actually engage in the change, and third, refreezing, in which the new
change is integrated into the system and becomes part of the new norm or culture.
Lewin’s (1951) change method theory points out that human behavior is variable among
individuals or groups based on their environment at any particular time. Lewin (1951)
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focused on social change, pointing out that “group life is never without change, merely
difference in amount and time and type of change exist” (p. 199). Lewin’s (1951) field
theory proposes maintaining the status quo, or a state of equilibrium, when restraining
forces and driving forces balance each other. To achieve change, the restraining forces
must be weakened and the driving forces strengthened (Kearney, 2001). Increasing
incentives with the use of position power to force change is one approach to increase the
driving forces that achieve change (Yukl, 2010). Restraining forces maintain the status
quo and resist change. They include norms, values, relations among people, morals, fears,
perceived threats, and regulations (Kearney, 2001). Reducing fear or failure, economic
loss, or removing opponents reduce restraining forces that create resistance to change
(Yukl, 2010). Driving forces support change, and include the desire to please or the
desire for new, effective, or efficient activities (Kearney, 2001). System imbalance
becomes the impetus for change (Kearney, 2001).
While all these changes in quality improvement and reporting based on compliance
with STK measures initially seemed overwhelming, the outcome enhanced the care
delivered to stroke patients.
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CHAPTER IV
Project Plan
The steps and procedures in the CDC Framework for Program Evaluation have been
used for the evaluation of the stroke patient care program (see Appendix C). Program
improvement was the focus of the evaluation. Mateo & Kirchhoff’s (2009) suggest that
program staff is trained to identify disparities between program objectives and the needs
of the target population. Also, discrepancies between program implementation and
program plans should be identified and addressed. The final disparity that can be
identified is one that may exist between the expectations of the target population and the
services actually delivered. Identification of three of these discrepancies is vital in order
to provide ongoing information to the program.
Setting. This rural hospital provides regional healthcare services to the second largest
county in the state (U.S. Census Bureau, 2011b). This rural Nevada is the only hospital in
this services area and borders Idaho on the north and Utah on the east. Elko is 300 miles
east of Reno, 240 miles west of Salt Lake City, and 250 miles south of Boise.
Population of interest. The population is defined as a collection of patients sharing a
common set of universally measured characteristics of ICD-9 CM principle diagnosis of
ischemic stroke.
Measures/instruments/activities. The steps in the CDC framework provide a
fundamental set of standards of utility, feasibility, propriety, and accuracy for program
evaluation (U.S. Department of Health and Human Services,2005). The CDC standards
are used in each step of the CDC framework as a guide to keep options of evaluation
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manageable by identifying credible evidence that is the most useful (U. S. Department of
Health and Human Services, 2005). For a look at evaluation standards, see Appendix E.
Domains of performance include appropriateness, continuity, effectiveness,
prevention/early detection, and timeliness. Measurement of related outcomes include:
mortality, decreased mortality, readmissions within 30 days, decreased reliability,
increased delivery of evidence-based care, and improvement noted as increase in rate.
Timeline.
April 2011
•

Defense of capstone proposal

•

Revisions to proposal

April – September 2011
•

Gather credible evidence: Data collection of stroke core performance
measures using a retrospective method for review of the second and third
quarters of the year.

October – December 2011
•

Justify conclusions: Data analysis, interpretation, and recommendations

January – March 14, 2012
•

Ensure use and share lessoned learned

•

Completion of program evaluation report

March 29, 2012
•

Defend Capstone Project

Resources. The most important component of the program evaluation has been
access to data. No funding was necessary for program evaluation completion. As an
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employee of the hospital, privilege was granted to participate in the review and the
gathering of Stroke Core Performance Measures, which consists of reportable data as part
of continuous quality improvement.
IRB approval. In this program evaluation of stroke protocol in a rural hospital,
research activities posed no risk to subjects. However, ethical considerations should be
deliberated with any research activity involving human -subjects for research. “As the
lines between quality improvement activities and research blur, the tendency for these
projects to undergo review by IRBs is stronger than in the past” (Zaccagnini & White,
2011, p. 456). The application for Internal Review Board (IRB) approval was completed
as required and. This program evaluation received exempt status from the University of
Nevada Las Vegas.
Evaluation Plan
Step one: Engage key stakeholders, such as those involved in program operations,
those served or affected by the program, and those who are intended users of evaluation
findings (U.S. Department of Health and Human Services, 2005). A meeting with
stakeholders took place to clarify the intent of the evaluation and a formal letter hospital
approval was acquired to evaluate the stroke program (see Appendix G).
Step two: Describe the program with a comprehensive description that clarifies need,
targets, potential outcomes, implementation, and resources. (U.S. Department of Health
and Human Services, 2005). The methods for sampling, data collection, data analysis,
interpretation, and judgment were described. This program evaluation describes program
strategies over the third and fourth quarters of 2010, as well as the first, second, and third
quarters of 2011, that have been initiated in order to reduce the burden of neurological
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disease with the application of a stroke protocol that complies with defined goals for the
assessment and management of stroke victims.
Step three: Focus the evaluation design with stakeholders to define the purpose and
potential applications of evaluation (U.S. Department of Health and Human Services,
2005). The Application of the Centers of Disease Control (CDC) Framework for Program
Evaluation offered a focused approach to answer evaluation questions with the STK
measure set that the stakeholders agreed were useful, feasible, ethical, and accurate
Step four: Credible evidence was gathered through the consideration of indicators,
sources of evidence/ methods of data collection (U.S. Department of Health and Human
Services, 2005). The program evaluator, with the assistance of the hospital’s utilization
review board, selected patient charts at the end of each quarter based on the ICD code
table for stroke diagnoses (See Appendix C). For the purpose of this program evaluation,
Starla Ricks MSN, FNP-BC functioned as the program evaluator. The Stroke Core
Performance Measures, which consist of Joint Commission & CMS reportable data, were
abstracted to determine whether measures have or have not been met. Data abstraction
took place following the last day of the previous quarter. Subsequently, all data compiled
and interpreted was based on stroke performance measures.
Step 5: Justify conclusions by “analyzing the evidence, making claims about the
program based on the analysis, and justifying the claims by comparing the evidence
against stakeholder values” (U.S. Department of Health and Human Services, 2005,
p.16). Analysis and synthesis of quarterly STK core performance measure findings pre
and post protocol detected patterns in evidence.
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Step 6: Ensure use of evaluation findings and shared lessons learned in order to
improve the program. Relevant recommendations, proper preparation, feedback, followups, and the dissemination of information are all essential components of program
applicability (U.S. Department of Health and Human Services, 2005). Perform final
evaluation of the program based on data findings. Standards of utility, propriety, and
accuracy most directly relate to ensuring use and sharing lessons learned (U.S.
Department of Health and Human Services, 2005). The justified evaluation conclusions
are based on the evidence including standards, analysis and synthesis, interpretation,
judgment, and recommendations.
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CHAPTER V
Summary of Implementation/Results
Initiation of the project. The Joint Commission (2010) Specification Manual for
Joint Commission National Quality Core Measures defines the population and sampling
specifications: The population was defined as a collection of patients sharing a common
set of universally measured characteristics that included ICD-9-CM Diagnosis, and the
sample size requirements determined the number of cases to sample. In order to achieve a
representative sample of the patient population there needs to be a fairly large number of
cases to sample. In this rural hospital the average quarterly patient population equaled a
patient population size of 7.8 which necessitated collecting data for the entire population.
Threats and barriers to the project. There were challenges faced by this rural
hospital that included resistance from the physicians to the changes being implemented.
At this rural hospital, physicians referred to the new protocol for STK core performance
measure compliance as “cookbook medicine,” and argued that adhering to quality
guidelines detracted from their ability to use their own judgment and experience. The
rural hospital addressed these concerns in several ways, including naming the hospitalist
as physician champion to communicate and coordinate the change efforts among
physician colleagues. At the same time, physicians and hospital clinical staff received
education on the evidence-based research behind the measures and the importance of
compliance necessary to ensure that they achieve high standards of care.
Monitoring of the project. The hospital samples were monitored to ensure that
sampling procedures consistently produced statistically valid and useful data. Detailed
measure specifications, including population identifiers, inclusion and exclusion criteria,
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and data element definitions were associated with each of the Stroke (STK) performance
measures.
Data collection. Stroke programs should be collecting data for eight of the
standardized stroke (STK) measures (Joint Commission, 2010). Data collection includes
eight standardized measures on a quarterly basis with the provision that monthly data
points are gathered and reported. Data was collected through patient chart abstraction
using ICD code tables of stroke measures. This program evaluation includes retrospective
data sources for administrative data and medical records.
The measure set is applicable to patients with diagnosis of ischemic stroke. The
numerator within the stroke performance measure is the number of stroke patients that
receive treatment within the guidelines of the stroke performance measure. The
denominator is the number of stroke patients in total. Exclusions to the population
include patients younger than 18 years of age, patients who left against medical advice,
patients who expired, and patients admitted for the performance of elective carotid
intervention.
•

STK-1: Venous Thromboembolism (VTE) Prophylaxis

Numerator: Ischemic or hemorrhagic stroke patients who received VTE prophylaxis
or have documentation why no VTE prophylaxis was given on the day of or the day after
hospital admission
Denominator: Ischemic stroke patients
•

STK-2: Discharged on Antithrombotic Therapy

Numerator: Ischemic stroke patients prescribed antithrombotic therapy at hospital
discharge
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Denominator: Ischemic stroke patients
•

STK-3: Anticoagulation Therapy for Atrial Fibrillation/Flutter

Numerator: Ischemic stroke patients prescribed anticoagulation therapy at hospital
discharge
Denominator: Ischemic stroke patients with documented atrial fibrillation/flutter
•

STK-4: Thrombolytic Therapy

Numerator: Acute ischemic stroke patients for whom thrombolytic therapy was
initiated at this hospital within 3 hours (< 180 minutes) of identification signs of stroke
Denominator: Acute ischemic stroke patients whose time of arrival is within 2 hours
(< 120 minutes) of identification signs of stroke
•

STK-5: Antithrombotic Therapy by End of Hospital Day 2

Numerator: Ischemic stroke patients who had antithrombotic therapy administered by
end of hospital day 2
Denominator: Ischemic stroke patients
•

STK-6: Discharged on Statin Medication

Numerator: Ischemic stroke patients prescribed statin medication at hospital
discharge
Denominator: Ischemic stroke patients with an LDL > 100 mg/dL, OR LDL not
measured, OR who were on a lipid-lowering medication prior to hospital arrival
•

STK-8: Stroke Education

Numerator: Ischemic or hemorrhagic stroke patients with documentation that they or
their caregivers were given educational material addressing all of the following:
1. Activation of emergency medical system
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2. Need for follow-up after discharge
3. Medications prescribed at discharge
4. Risk factors for stroke
5. Warning signs for stroke
Denominator: Ischemic stroke patients discharged home
•

STK-10: Assessed for Rehabilitation

Numerator: Ischemic or hemorrhagic stroke patients assessed for, or who received
rehabilitation services
Denominator: Ischemic stroke patients
Data analysis. Data was analyzed using the statistical package for the social sciences
(SPSS). Data analysis included log-linear regression of one hundred percent of the
quarterly initial patient population of ischemic stroke cases.
To assess whether the stroke protocol was significant in increasing the number of
correctly diagnosed patients, a log-linear regression analysis was conducted. Combining
the two pre-protocol quarters data (3rd and 4th quarters of 2010) and comparing that to the
three post-protocol quarters data (1st, 2nd, and 3rd quarters of 2011), the interaction
between pre and post-protocol diagnoses was significant, Z = 3.28, p = .001. The
parameter estimate (.429) indicated an odds ratio of 1.54 which can be interpreted as 54%
increase, or, in other words, patients were 54% more likely to be diagnosed correctly
after the stroke protocol was implemented. Further assessment of the individual STK
measures showed that four of the eight measures (STK 7 and STK 9 were not used in this
evaluation) significantly differed from pre-protocol to post-protocol: a binomial test
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indicated that STK 1 (p = <.0005), STK 2 (p = <.0005), STK 6 (p = <.0005), and STK 8
(p = <.0005) all significantly increased at an alpha level of p = .025 (one tailed test).

Table 1

Results

STK

Diagnosed/Total

% Diagnosed Diagnosed/Total

% Diagnosed

Measure

(Pre-protocol)

(Pre-

(Post-protocol)

(Post-protocol)

protocol)
1

3/7

43%

15/16

94%

2

7/8

88%

13/13

100%

3

1/1

100%

2/2

100%

4

0/1

0%

0/1

0%

5

6/7

86%

13/14

93%

6

1/3

33%

6/6

100%

8

1/6

17%

5/8

63%

10

8/8

100%

14/14

100%

Giving Meaning to the Data
Log-linear regression is used for assessing relationships where the dependent variable
is dichotomous. Logistic regression is useful when at least one of the independent
variables is continuous whereas log-linear regression is typically used when both the
independent and dependent variables are dichotomous. The individual comparisons of the
STK measures were limited sample sizes and the outcome was dichotomous. It was not
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possible to do a repeated measures t-test. The binomial test uses a binomial distribution
and is useful for comparing two proportions or counts, which is applicable to this study.
To see if the percentages were significantly different the binomial test compared the
number of patients who were diagnosed correctly vs. incorrectly to the proportion of
successes prior to the protocol. Suggestions to further examine the individual protocols
would be to collect more data so that one could at least use a normal approximation rather
than the binomial distribution to assess differences.
Descriptive statistics were used to describe sample characteristics and frequencies
including gender, age, and Ferri’s (2011) risk factors for ischemic stroke including
diabetes mellitus, hypertension, smoking, family history of premature vascular disease,
hyperlipidemia, atrial fibrillation, history of TIA, history of recent myocardial infarction,
and history of congestive heart failure. Descriptive statistical findings were as such: 14
males, 25 females, ages 44 years-of-age to 92 years-of-age, 12.8% of the patients had
diabetes mellitus, 25% of the patients had hypertension, 7% of the patients smoked or had
a history of tobacco use, 5% of the patients had a history of recent myocardial infarction,
and 23% had a history of congestive heart failure.
Dissemination and Utilization of Results
The goal for dissemination is to achieve full disclosure and impartial reporting that
ensures that the stakeholders are aware of the evaluation procedures and findings (CDC,
1999) An essential step in program evaluation is writing an evaluation plan and
disseminating the report is to stakeholders (Mateo & Kirchoff, 2009). A plan to provide a
program evaluation report of the results of the project has been discussed and agreed
upon with the stakeholders. The program evaluation report ensures that the information
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needs of relevant audiences will be met. Mateo and Kirchoff (2009) describe the 10
components of the program evaluation report which will include the purpose of the
report; the nature of the clinical program and its components parts; the setting of the
program; the time frame for the program; the program staff resources used; the way the
data obtained during the formative evaluation were used to alter the program and improve
its implementation process; the evaluation methods used, including the evaluation of the
program process and outcome variables; results of data analysis; recommendations for
program revisions, refinement, and continuation; and a summary of the program’s overall
effectiveness in achieving its designed purpose.
By applying the principles of the CDC framework into the program evaluation of
stroke protocol in a rural Nevada hospital both the procedures used and the lessons
learned from the evaluation can be utilized as a driving force for improving the existing
stroke care and account for health promotion and disease intervention. The stroke
protocol was significant in increasing the number of correctly diagnosed patients and
assessment of the individual STK measures showed that four of the eight measures
significantly differed from pre-protocol to post-protocol.
The systematic use of this stroke protocol supported the use of evidence-based
practice guidelines and improved compliance with standards. The stroke protocol must be
kept current to incorporate subsequent scientific evidence. Given this research
perspective, the program evaluation, with a population perspective and ensuing data
analysis, serves to provide further relevant data engaged in the pursuit of lessening this
health care disparity.
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APPENDIX A
DEFINITION OF TERMS
PROGRAM EVALUATION DEFINITIONS
U.S. Department of Health and Human Services, 2005
Program evaluation: The systematic collection of information about the activities,
characteristics, and outcomes of programs to make judgments about the program,
improve program effectiveness, and/or inform decisions about future program
development.
Stakeholders: People or organizations that are invested in the program or that are
interested in the results of the evaluation. Stakeholders include organizations, hospitals,
clinical professionals, and, health care consumers
Standards: A principle commonly agreed upon by experts in the conduct and use of
an evaluation for the measure of the value or quality of an evaluation (e.g., accuracy,
feasibility, propriety, utility).
Accuracy: The extent to which an evaluation is truthful or valid in what it says about
a program, project, or material.
Feasibility: Planned evaluation activities realistic given the time, resources, and
expertise at hand.
Propriety: The extent to which the evaluation has been conducted in a manner that
evidences uncompromising adherence to the highest principles and ideals (including
professional ethics, civil law, moral code, and contractual agreements).
Utility: The extent to which an evaluation produces and disseminates reports that
inform relevant audiences and have beneficial impact on their work.
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STROKE DEFINITIONS
McCance and Huether, 2009
Ischemic Stroke: result when an artery to the brain is block, often by a blood clot or
a fatty deposit due atherosclerosis.
Thrombotic Stroke: arterial occlusions caused by thrombi formed in the arteries
supplying the brain or intracranial vessels.
Transient Ischemic attacks: thrombotic particles causing an intermittent blockage of
circulation or spasm.
Embolic Stroke: involves fragments that break from a thrombus formed outside the
brain or in the heart, aorta, common carotid, or thorax.
The Joint Commission, 2010 Core Performance Measure: one common set of
measure specifications. The goal is to minimize data collection efforts for these common
measures and focus efforts on the use of data to improve the health care delivery process.
Center for Disease Control and Prevention, 2011 The International
Classification of Diseases (ICD): is designed to promote international comparability in
the collection, processing, classification, and presentation of mortality statistics.
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APPENDIX B
STK CORE MEASURES

Stroke (STK) Core Measure Set

STK-1

Venous Thromboembolism (VTE) Prophylaxis@

STK-2

Discharged on Antithrombotic Therapy@

STK-3

Anticoagulation Therapy for Atrial Fibrillation/Flutter@

STK-4

Thrombolytic Therapy@

STK-5

Antithrombotic Therapy By End of Hospital Day 2@

STK-6

Discharged on Statin Medication@

STK-8

Stroke Education@

STK-10

Assessed for Rehabilitation@

@ denotes Accountability evaluation pending
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APPENDIX C
ICD 9 CODES
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APPENDIX D
STROKE PROTOCOL
(Attached pages)
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APPENDIX E
CDC FRAMEWORKS

57

58

APPENDIX F
STROKE MAPS
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APPENDIX G
BRFSS DATA
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APPENDIX H
ORGANIZATIONAL CHART
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APPENDIX I
LETTER OF CONSENT
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APPENDIX J
IRB APPROVAL

Biomedical IRB
Notice of Excluded Activity

DATE:

TO:

FROM:

RE:

January 27, 2012

Dr. Patricia Smyer, School of Nursing

Office of Research Integrity – Human Subjects

Notification of IRB Action

Protocol Title: Program Evaluation of Stroke Protocol in a Rural Nevada
Hospital
Protocol# 1201-3997
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________________________________________________________________________
__________

This memorandum is notification that the project referenced above has been reviewed
as indicated in Federal regulatory statutes 45CFR46.

The protocol has been reviewed and deemed excluded from IRB review. It is not in
need of further review or approval by the IRB.

Any changes to the excluded activity may cause this project to require a different level
of IRB review. Should any changes need to be made, please submit a Modification
Form.

If you have questions or require any assistance, please contact the Office of Research
Integrity – Human Subjects at IRB@unlv.edu or call 895-2794.

66

References
Accountable Care Organizations (2009). Reforming Provider Payment: Moving Toward
Accountability for Quality and Value. Retrieved from
http://sharepoint.lpnt.corpad.net/sites/reform.
American Evaluation Association. (2008). Guiding principles for evaluators. Retrieved
from http://www.eval.org/Publishcation/Guidling/PrinciplesPrintable.asp
American Heart Association (2001). Development of Performance Measures for Acute
Ischemic Stroke. Retrieved from
http://stroke.ahajournals.org/cgi/content/full/32/9/2058
American Heart Association (2006). Get with the stroke guidelines. Retrieved from
http://americanheart.org/getwiththeguidlines.
American Heart Association (2008). Stroke in Rural Areas and Small Communities.
Retrieved from http://stroke.ahajournals.org/cgi/content/full/39/6/1920
Arcangelo, V. P., & Peterson, A. M. (2006). Pharmacotherapeutics for advanced practice
(2nd ed.). Philadelphia: Lippincott, Williams & Wilkins.
Assam, I. (2011). Nevada state comprehensive profile for stroke prevention 2011.
Nevada Office of Epidemiology, Nevada State Health Division. Retrieved from
health.nv.gov/PDFs/HSPER/StrokeBook1.pdf
Billings, J. R. (2000). Community development: A critical review of approaches to
evaluation. Journal of Advanced Nursing, 31(2), 472-480.
Boutotte, J., Wilce, M., & Etkind, S. (2003). Using the CDC framework for program
evaluation in public health to assess tuberculosis contact investigation programs.
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/14677826

67

Burke, M. M., & Laramie, J. A. (2004). Primary care of the older adult a
multidisciplinary approach (2nd ed.). St. Louis, Missouri: Mosby.
Casper, M. L., Wing, S., Anda, R. F., Knowles, M., & Polland, R. A. (2011). Changes in
the geographic pattern of stroke mortality in the United States. American Heart
Association, 26, 755-760. Retrieved from
http://stroke.ahajournals.org/content/26/5/755.short
Centers of Disease Control (2008). Evaluation Working Group. Retrieved from
http://www.cdc.gov/eval
Centers for Disease Control and Prevention. (2011a). Behavioral risk factor surveillance
system: BRFSS maps. Office of Surveillance, Epidemiology, and Laboratory
Service. Retrieved from http://www.cdc.gov/brfss/maps/faqs.htm
Centers for Disease Control and Prevention. (2011b). Classification of Diseases,
Functioning, and Disability. Retrieved from
http://www.cdc.gov/nchs/icd/icd9.htm
Centers for Disease Control and Prevention/National Center for Health Statistics. (1999).
Current estimates from the national health interview survey. Vital Health
Statistics, 10(20). Retrieved from
http://www.cdc.gov/nchs/data/series/sr_10/sr10_200.pdf
Centers for Medicare & Medicaid Services. (2010). Telemedicine and Telehealth.
Retrieved from https://www.cms.gov/Telemedicine/
Christensen, C. M., Grossman, J.H., and Hwang, J. (2009). The innovator's prescription:
A disruptive solution for health care. New York: McGraw-Hill.

68

Ferri, F. (2011). Clinical advisor: Instant diagnosis and treatment. Philadelphia: Mosby
Elsevier.
Hinshaw, A. S., & Grady, P. A. (2011). Shaping health policy through nursing research.
Springer Publishing Company.
Joubert, J., Prentice, L. F., Moulin, T., Liaw, S. T., Joubert, L. B., Preux, P.M....McLean,
A. (2008). Stroke in rural area and small communities. Stroke, 39, 1920-1928.
doi:10.1161/STROKEAHA.107.501643
Joint Commission (2010). Measure Sets. Retrieved from
http://www.jointcommission.org/core_measure_set/
Kearney, R. (2001). Advancing your career (2nd ed.). Philadelphia: F.A. Davis
Company.
Kochanek, K. D., Jiaqual, M. A., Murphy, S. L., Minino, A. M., & Kung, H. (2011).
Deaths: Preliminary data for 2009. National Vital Statistics Reports, 59(4), 1-13.
LaBresh, K. A. (2008). Stroke core measures: Strategies for success. Blackstone Health
Consulting. Retrieved from
http://scorema.org/PDFs/Labresh_stroke_as_a_core_measure12_03_08.pdf
Lewin, K. (1951). Field theory in social science. New York: Harper & Row.
Mateo, M., & Kirchhoff, K. (2009). Research for advanced practice nurses: From
evidence to practice. Springer Publishing Company.
McCance, K. L., & Huether, S. E. (2009). Pathophysiology: The biologic basis for
disease in adults and children (6th ed.). St. Louis: Elsevier Mosby.
McLaughlin, C. P., & Kaluzny, A. D. (2006). Continuous quality improvement in health
care: Theory, implementations, and applications. Jones & Bartlett.

69

Michota, F. A. (2007). Bridging the gap between evidence and practice in venous
thromboembolism prophylaxis: The quality improvement process. J Gen Intern
Med. 22(12), 1762–1770. doi: 10.1007/s11606-007-0369-z
Milken Institute. (2007). An unhealthy America: The economic impact of chronic
disease. Retrieved from
http://www.milkeninstitute.org/publications/publications.taf/function=detail&ID=
38801018&cat-resrep.
National Conference of State Legislatures. (2011). Nevada State Profile and Policy
Report. Retrieved from http://www.ncsl.org/default.aspx?tabid=17948
National Institutes of Health. (2011). Thrombolytic therapy. Retrieved from
http://www.nlm.nih.gov/medlineplus/ency/article/007089.htm
Nevada State Health Division. (2011). Nevada Comprehensive Profile for Stroke
Prevention. Retrieved from http://health.nv.gov/PDFs/HSPER/StrokeBook1.pdf
New York State Department of Health. (2010). Eliminating Childhood Lead Poisoning in
New York by 2010. Retrieved from
http://www.health.state,ny.us/environmental/lead/exposure/childhood/finalplanev
al.htm
Porterfield, D. S, Hinnant, L., Stevens, D. M., Moy, E. (2010). Diabetes primary
prevention initiative interventions focus area: A case study and recommendations.
American Journal of Preventive Medicine, 39(3), 235-242.
Strong, K., Mathers, C., Bonita, R. (2007). Preventing stroke: Saving lives around the
world. Lancet Neurol, 6(2), 182-7. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/17239805

70

The Joint Commission. (2011). Stroke. Retrieved from
http://www.jointcommission.org/stroke/
Urden, L. D., Stacy, K. M., & Lough, M. E. (2009.) Priorities in critical care nursing (4th
ed.). St. Louise: Mosby.
U.S. Census Bureau. (2011a). Elko County quick facts from the U.S. Census Bureau.
Retrieved from http://www.quickfacts.census.gov/qfd/states/32/32007.html
U.S. Census Bureau. (2011b). State and county quick facts: Nevada. Retrieved from
http://quickfacts.census.gov/qfd/states/32/3260600
U.S. Department of Health and Human Services. (2005). Introduction to program
evaluation for public health programs: A self-study guide. Retrieved from
www.cdc.gov/getsmart/program-planner.html
U.S. Department of Health and Human Services (1999). Framework for program
evaluation in public health. Morbidity and Mortality Weekly Report, 48, 1-40.
Wilson, S., & Giddens, J. (2008). Health assessment for nursing practice (4th ed.). St.
Louis: Elsevier Mosby.
Yukl, G. (2010). Leadership in organizations. Upper Saddle River, NJ: Prentice Hall.
Zaccagnini, M., & White, K. (2011). The doctor of nursing practice essentials. Sudbury,
MA: Jones and Bartlett.

71

CURRICULUM VITA
Starla C. Ricks
283 Brooklawn Drive
Spring Creek, Nevada 89815
(775)753-8579
Sricks57@frontiernet.net
EDUCATION
2010-2012 University of Nevada, Las Vegas
Las Vegas, Nevada
Doctor of Nursing Practice 2012
2006-2009 University of Nevada, Las Vegas
Las Vegas, Nevada
Family Nurse Practitioner Program
Master of Science-Nursing 2009
2004-2006 Great Basin College
Elko, Nevada
Bachelor of Science-Nursing 2006
1997-2000

North Idaho College
Coeur d’Alene, Idaho
Associate in Science-Nursing 2000

PROFESSIONAL EXPERIENCE
2010- Present NORTHEASTERN NEVADA REGIONAL HOSPITAL
Elko, Nevada
Nursing Administration
Director of Wells Family Medicine
Family Nurse Practitioner – Board Certified
2009-2010 NEVADA HEALTH CENTERS, INC
Elko, Nevada
Family Nurse Practitioner – Board Certified
2006-2009 NORTHEASTERN NEVADA REGIONAL HOPITAL
Elko, Nevada
Director of Intensive Care & Medical/Surgical/Pediatrics & Education
Services

72

2005-2006 NORTHEASTERN NEVADA REGIONAL HOSPITAL
Elko, Nevada
Nursing House Supervisor
2000-2005 NORTHEASTERN NEVADA REGIONAL HOSPITAL
Elko, Nevada
Registered Nurse
1999-2000 SILVERWOOD GOOD SAMARITAN CENTERS
Silverton, Idaho
Licensed Practical Nurse:
1991-1999 SILVERWOOD GOOD SAMARITAN CENTERS
Silverton, Idaho
Nursing Assistant Certified:
MEMBERSHIPS AND COMMITTEE WORK
2006-2009 National Honor Society Members
2006 Magna cum Laude
2006 Great Basin College’s outstanding nursing student of the year.
2005-2009 NNRH Pediatric Committees
2007-2009 NNRH Patient Satisfaction Committees
2008-2009 Wound Care Committees
2010-2012 NNRH Policy Committees

73

